William Mansfield

Recent Posts

Application fields and active protection - A closer look at the top 20 Universities and Research centers

Posted by William Mansfield on Jan 11, 2019 3:53:59 PM

For a study commissioned by IAM, PatentSight has taken a closer look at the patenting activity of leading universities and research centres based on the Patent Asset IndexTM.

Read More

Tags: Patent Asset Index, Innovation, Science, Technology


The Transformation into the New Takeda

Posted by William Mansfield on Apr 27, 2018 3:51:06 PM

In 2011 faced with “the impending loss of patent protection on certain leading products”, the Takeda Pharmaceutical Company unveiled its mid-term plan to achieve sustainable growth. Over the 10 years prior to this Takeda had pruned its patent portfolio significantly from over 3500 patent families in the year 2000 to less than 1900 in 2008, saving the company millions of dollars over the lifetime of these patents. Whilst such cost saving measures would have reduced the company’s liabilities, this alone would have not ensured long-term prosperity. Enter the “New Takeda”.

Read More

Tags: Mergers and Acquisitions


Becton Dickinson secures itself as a healthcare innovation leader with Bard acquisition

Posted by William Mansfield on Apr 12, 2018 7:41:00 AM

Becton Dickinson’s 24bn USD acquisition of U.S. peer C.R. Bard, as reported by Reuters, has secured its position as one of the top 10 global healthcare companies in terms of both revenue and innovation. Although the combined company will still wield a smaller patent portfolio than the industry giants, the average quality of the portfolio is significantly above average, surpassed only by Johnson & Johnson. This high quality means the combined entity now has 6th strongest portfolio in the field of healthcare, as defined by ip-search a division of the CHPTO, out of the top 30 medical device manufacturers, by annual revenue reported in MPO magazine.

Read More

Tags: Mergers and Acquisitions, Innovation, Patent Asset Index, Regulation